Displaying 1 - 50 of 118 results
Released Company Title Industry Topic
06 Oct 2020
07:55 CEST
ESPERITE ESPERITE N.V. announces the voting results for the Extra-ordinary General Meeting of Shareholders of ESPERITE N.V. held on Wednesday 30 September 2020. 20101025 Health Services Change in Capital
18 Sep 2020
19:45 CEST
ESPERITE ESPERITE N.V. announces that due to sanitary constraints the Extraordinary General Meeting of Shareholders scheduled on 30 September 2020 will be organized by audio and video conference. 20101025 Health Services General meeting / Board Meeting, Meetings / events
18 Sep 2020
19:45 CEST
ESPERITE ESPERITE N.V. announces that due to sanitary constraints the Extraordinary General Meeting of Shareholders scheduled on 30 September 2020 will be organized by audio and video conference. 20101025 Health Services General meeting / Board Meeting, Meetings / events
19 Aug 2020
19:50 CEST
ESPERITE ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders to approve external financing 20101025 Health Services Other subject
05 Aug 2020
07:35 CEST
ESPERITE Esperite NV annonce un changement de direction et engage son nouveau CEO, Mr. Hugo Brugière. 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
05 Aug 2020
07:35 CEST
ESPERITE Esperite NV annonce un changement de direction et engage son nouveau CEO, Mr. Hugo Brugière. 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
05 Aug 2020
07:25 CEST
ESPERITE Esperite NV announces a major change in its management and appoints its new CEO, Mr. Hugo Brugière. 20101025 Health Services Other subject
29 Jul 2020
11:45 CEST
ESPERITE Esperite NV sécurise un financement jusqu'à 35 millions d'euros sous forme d'obligations convertibles avec bons de souscription d'actions attachés pouvant être tirées sous certaines conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
29 Jul 2020
11:45 CEST
ESPERITE Esperite NV sécurise un financement jusqu'à 35 millions d'euros sous forme d'obligations convertibles avec bons de souscription d'actions attachés pouvant être tirées sous certaines conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
29 Jul 2020
09:45 CEST
ESPERITE Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
29 Jul 2020
09:45 CEST
ESPERITE Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Jul 2020
20:45 CEST
ESPERITE Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Jul 2020
20:45 CEST
ESPERITE Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions 20101025 Health Services Alliances and agreements, Mergers, Acquiqitions, Transferts
24 Feb 2020
14:15 CET
ESPERITE ESPERITE (ESP) will oppose the decision of the AFM and object to the fine. Biotechnology Other subject
18 Feb 2020
22:00 CET
ESPERITE ESPERITE confirms the investigation on its former subsidiary CryoSave Biotechnology Other subject
17 Feb 2020
05:55 CET
ESPERITE ESPERITE N.V updates on the current business Biotechnology Other subject
14 Feb 2020
16:00 CET
ESPERITE ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020 Biotechnology Other subject
10 Feb 2020
07:17 CET
ESPERITE Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory. Biotechnology Commercial operations
30 Oct 2019
08:59 CET
ESPERITE ESPERITE (ESP) is not bankrupt Biotechnology Corporate life
14 Oct 2019
05:59 CEST
ESPERITE Esperite (ESP) disputes the Court verdict and appeals the bankruptcy order. Biotechnology Corporate life
01 Oct 2019
10:33 CEST
ESPERITE Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Biotechnology New
19 Sep 2019
13:26 CEST
ESPERITE CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business. Biotechnology Other subject
27 Aug 2019
15:54 CEST
ESPERITE ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS Biotechnology Mergers, Acquiqitions, Transferts
04 Jul 2019
08:58 CEST
ESPERITE Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report Biotechnology New
02 Jul 2019
08:47 CEST
ESPERITE ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. Biotechnology Products and services
01 Jul 2019
07:17 CEST
ESPERITE ESPERITE NV (ESP) COM CRYOSAVE CONFIRMA A SEGURANÇA DE TODAS AS AMOSTRAS ARMAZENADAS E AGRADECE ÀS 260.000 FAMÍLIAS PELA SUA CONFIANÇA. Biotechnology Alliances and agreements
01 Jul 2019
07:17 CEST
ESPERITE ESPERITE NV (ESP) MET CRYOSAVE BEVESTIGT DE VEILIGHEID VAN ALLE OPGESLAGEN STALEN EN DANKT DE 260.000 FAMILIES VOOR HUN VERTROUWEN. Biotechnology Alliances and agreements
01 Jul 2019
07:17 CEST
ESPERITE ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE. Biotechnology Alliances and agreements
01 Jul 2019
07:17 CEST
ESPERITE ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE. Biotechnology Alliances and agreements
30 Jun 2019
21:01 CEST
ESPERITE ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business. Biotechnology New
28 Jun 2019
23:51 CEST
ESPERITE Esperite N.V.: Update to the market on the publication of the Annual Report 2018 Biotechnology New
25 Jun 2019
22:59 CEST
ESPERITE ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject
14 Jun 2019
08:54 CEST
ESPERITE ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes Biotechnology Other subject
13 Jun 2019
07:17 CEST
ESPERITE ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject
04 Jun 2019
10:18 CEST
ESPERITE Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution. Biotechnology Other subject
29 May 2019
08:26 CEST
ESPERITE ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale Biotechnology Other subject
19 May 2019
22:54 CEST
ESPERITE ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019) Biotechnology Other subject
13 May 2019
07:17 CEST
ESPERITE Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration. Biotechnology Other subject
01 May 2019
16:58 CEST
ESPERITE Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018 Biotechnology Other subject
05 Apr 2019
07:17 CEST
ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject
27 Feb 2019
07:17 CET
ESPERITE Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia. Biotechnology Other subject
26 Feb 2019
07:17 CET
ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject
22 Feb 2019
07:17 CET
ESPERITE ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS. Biotechnology Other subject
10 Jan 2019
07:17 CET
ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today Biotechnology Other subject
30 Nov 2018
07:17 CET
ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today Biotechnology Other subject
29 Nov 2018
07:17 CET
ESPERITE Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates. Biotechnology Other subject
27 Nov 2018
18:26 CET
ESPERITE ESPERITE N.V. convenes Annual General Meeting of Shareholders Biotechnology Other subject
23 Nov 2018
23:35 CET
ESPERITE ESPERITE (ESP): financial results for 2017 are published. Biotechnology Other subject
19 Nov 2018
15:35 CET
ESPERITE ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018 Biotechnology Other subject
09 Nov 2018
07:17 CET
ESPERITE ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018 Biotechnology Other subject